Corient Capital Partners, LLC Enzo Biochem Inc Transaction History

Corient Capital Partners, LLC

  • $1.34 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 04, 2020
SELL
$2.57 - $3.68 $30,405 - $43,538
-11,831 Closed
0 $0
Q3 2019

Nov 06, 2019
SELL
$3.01 - $4.0 $210 - $280
-70 Reduced 0.59%
11,831 $43,000
Q2 2019

Aug 08, 2019
BUY
$2.79 - $4.31 $1,587 - $2,452
569 Added 5.02%
11,901 $40,000
Q1 2019

May 10, 2019
BUY
$2.54 - $4.02 $28,783 - $45,554
11,332 New
11,332 $31,000

Others Institutions Holding ENZ

# of Institutions
48
Shares Held
15.5M
Call Options Held
2.3K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $50.7M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email